
Lyell Immunopharma Executives Sell Shares Amid Concerns
Executives at Lyell Immunopharma, including the CEO, COO, and CSO, have sold shares totaling over $12,000. While these transactions are described as part of regular stock management, they have raised concerns regarding the company's financial health and stability among investors.

Claire's Appoints Administrators, 2,150 Jobs at Risk
Claire's, the fashion accessories chain, is set to appoint administrators for its operations in the UK and Ireland, putting approximately 2,150 jobs at risk. This decision follows the company's parent filing for bankruptcy in the US and Canada, although the shops will remain open as a potential sale is considered.

Kimball Electronics Reports Strong Q4 Earnings, Shares Surge

Nvidia and AMD to Pay 15% of China Sales to U.S.
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
4,164
176
191
4 hours ago
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more
Why World Pulse Now?
Global Coverage
All major sources, one page
Emotional Lens
Feel the mood behind headlines
Trending Stories
Know what’s trending, globally
Read Less, Know More
Get summaries. Save time
Multi-Language
Switch languages to read your way
Save for Later
Your stories, stored for later
Live Stats
4,164
176
191
4 hours ago
1-Minute Daily Briefing
Stay sharp in 60 seconds. Get concise summaries of today’s biggest stories — markets, tech, sports, and more